Iyona Rajkomar


Iyona joined Advent in 2015 as an Associate, bringing medical, public equity analysis, and consulting experience. She previously spent three years as a strategy consultant at PWC where her work involved corporate strategy, deal diligence and asset valuation in the pharma and biotech sector. Prior to that Iyona was an equity analyst for UBS and Bryan Garnier covering the European pharma and biotech space.

Iyona qualified as a medical doctor with Honours from St George’s Medical School and achieved the CFA charter in 2013.

Iyona was involved in founding Aleta Biotherapeutics and Itara Therapeutics and is a Board Observer on both companies. She is also a founder and Board Member of Alpha Anomeric.

View Iyona's profile on LinkedIn


Assistant: Amber Rosamond
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +44 (0)20 7932 2157